Fig. 4

Association of genetically predicted systolic blood pressure reduction for each major class of antihypertensive medications on the risk of atrial fibrillation or coronary heart disease. CI, confidence interval; ACEI, angiotensin-converting enzyme inhibitors; n, number; p, p value for heterogeneity between two outcomes, calculated using the chi-square test. Odds ratio estimated using the inverse-variance weighted method